WallStreetZenWallStreetZen

NASDAQ: AMPH
Amphastar Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for AMPH

Based on 5 analysts offering 12 month price targets for Amphastar Pharmaceuticals Inc

Min Forecast
$20.00-21.35%
Avg Forecast
$21.00-17.42%
Max Forecast
$23.00-9.56%

Should I buy or sell AMPH stock?

Based on 6 analysts offering ratings for Amphastar Pharmaceuticals Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
5 analysts 83.33%
Sell
1 analysts 16.67%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AMPH stock forecasts and price targets.

AMPH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-18
lockedlocked$00.00+00.00%2026-08-07
lockedlocked$00.00+00.00%2026-08-07
lockedlocked$00.00+00.00%2026-06-29
lockedlocked$00.00+00.00%2026-05-08
Jefferies
Bottom 10%
10
HoldDowngrades$22.00-13.49%2026-04-21

1 of 1

Forecast return on equity

Is AMPH forecast to generate an efficient return?

Company
14.69%
Industry
53.38%
Market
168.15%
AMPH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AMPH forecast to generate an efficient return on assets?

Company
6.47%
Industry
20.58%
AMPH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AMPH earnings per share forecast

What is AMPH's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$3.03+74.14%
Avg 2 year Forecast
$3.24+86.47%
Avg 3 year Forecast
$3.46+98.63%
AMPH's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

AMPH revenue forecast

What is AMPH's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$764.4M+4.71%
Avg 2 year Forecast
$801.4M+9.77%
Avg 3 year Forecast
$821.3M+12.5%
AMPH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AMPH earnings growth forecast

How is AMPH forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
25.71%
Industry
16.93%
Market
32.53%
AMPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
AMPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
AMPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

AMPH revenue growth forecast

How is AMPH forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
4.14%
Industry
9.42%
Market
14.51%
AMPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AMPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AMPH vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
AMPH$25.43$21.00-17.42%Hold
HROW$30.48$65.25+114.07%Strong Buy
PCRX$25.21$31.20+23.76%Buy
CRON$3.23N/AN/A
COLL$22.02$46.83+112.68%Buy
View Top Pharmaceutical Stocks

Amphastar Pharmaceuticals Stock Forecast FAQ

Is Amphastar Pharmaceuticals Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: AMPH) stock is to Hold AMPH stock.

Out of 6 analysts, 0 (0%) are recommending AMPH as a Strong Buy, 0 (0%) are recommending AMPH as a Buy, 5 (83.33%) are recommending AMPH as a Hold, 1 (16.67%) are recommending AMPH as a Sell, and 0 (0%) are recommending AMPH as a Strong Sell.

If you're new to stock investing, here's how to buy Amphastar Pharmaceuticals stock.

What is AMPH's earnings growth forecast for 2026-2028?

(NASDAQ: AMPH) Amphastar Pharmaceuticals's forecast annual earnings growth rate of 25.71% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 16.93%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.53%.

Amphastar Pharmaceuticals's earnings in 2026 is $78,547,000.On average, 9 Wall Street analysts forecast AMPH's earnings for 2026 to be $128,894,224, with the lowest AMPH earnings forecast at $107,969,809, and the highest AMPH earnings forecast at $144,671,548. On average, 9 Wall Street analysts forecast AMPH's earnings for 2027 to be $138,014,359, with the lowest AMPH earnings forecast at $108,803,553, and the highest AMPH earnings forecast at $160,793,428.

In 2028, AMPH is forecast to generate $147,015,388 in earnings, with the lowest earnings forecast at $130,480,889 and the highest earnings forecast at $163,919,967.

What is AMPH's revenue growth forecast for 2026-2028?

(NASDAQ: AMPH) Amphastar Pharmaceuticals's forecast annual revenue growth rate of 4.14% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 9.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.51%.

Amphastar Pharmaceuticals's revenue in 2026 is $730,019,000.On average, 9 Wall Street analysts forecast AMPH's revenue for 2026 to be $32,515,579,014, with the lowest AMPH revenue forecast at $29,635,334,826, and the highest AMPH revenue forecast at $34,213,268,359. On average, 9 Wall Street analysts forecast AMPH's revenue for 2027 to be $34,088,206,804, with the lowest AMPH revenue forecast at $30,406,547,751, and the highest AMPH revenue forecast at $37,714,991,909.

In 2028, AMPH is forecast to generate $34,935,562,648 in revenue, with the lowest revenue forecast at $31,086,304,096 and the highest revenue forecast at $38,342,426,583.

What is AMPH's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: AMPH) forecast ROA is 6.47%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 20.58%.

What is AMPH's Price Target?

According to 5 Wall Street analysts that have issued a 1 year AMPH price target, the average AMPH price target is $21.00, with the highest AMPH stock price forecast at $23.00 and the lowest AMPH stock price forecast at $20.00.

On average, Wall Street analysts predict that Amphastar Pharmaceuticals's share price could fall to $21.00 by Aug 18, 2027. The average Amphastar Pharmaceuticals stock price prediction forecasts a potential downside of 17.42% from the current AMPH share price of $25.43.

What is AMPH's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: AMPH) Amphastar Pharmaceuticals's current Earnings Per Share (EPS) is $1.74. On average, analysts forecast that AMPH's EPS will be $3.03 for 2026, with the lowest EPS forecast at $2.54, and the highest EPS forecast at $3.40. On average, analysts forecast that AMPH's EPS will be $3.24 for 2027, with the lowest EPS forecast at $2.56, and the highest EPS forecast at $3.78. In 2028, AMPH's EPS is forecast to hit $3.46 (min: $3.07, max: $3.85).

What is AMPH's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: AMPH) forecast ROE is 14.69%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.